Cytek Biosciences
United States
63 articles about Cytek Biosciences
-
Cytek® Biosciences Names William McCombe Chief Financial Officer
3/19/2024
Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately.
-
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
3/7/2024
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China.
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
2/28/2024
Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2023.
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
2/7/2024
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday, February 28th, 2024.
-
Cytek Biosciences to Participate in Upcoming Investor Conferences - February 07, 2024
2/7/2024
Cytek Biosciences, Inc., a leading cell analysis solutions company, announced the company will be participating in the following investor conferences.
-
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
1/17/2024
Cytek Biosciences, Inc. has signed an agreement with the Centre for Genomic Regulation and the Pompeu Fabra University to drive technological innovation and accelerate discoveries for the scientific community.
-
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
1/8/2024
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the full year ended December 31, 2023.
-
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
12/28/2023
Cytek Biosciences, Inc. announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
-
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
12/21/2023
Cytek Biosciences, Inc., a leading cell analysis solutions company, announced the introduction of the Cytek Orion™ reagent cocktail preparation system.
-
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
11/14/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, New York.
-
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
11/8/2023
Cytek Biosciences, Inc. announced that its Cytek® Aurora™ CS system has been selected as the “Cell Sorting Product of the Year” in the third annual BioTech Breakthrough Awards program.
-
Cytek Biosciences Reports Third Quarter 2023 Financial Results
11/7/2023
Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2023.
-
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
10/19/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third quarter 2023 after market close on Tuesday, November 7th, 2023.
-
Cytek® Biosciences Achieves ISO 13485 Certification at HeadquartersCertification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States
9/27/2023
Cytek Biosciences, Inc., a leading cell analysis solutions company, announced that it has received EN ISO 13485:2016 Quality Management System certification.
-
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
9/20/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of high parameter cell analysis by continuing to have an active presence at key industry events worldwide.
-
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
9/20/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 2023 Cantor Fitzgerald Global Healthcare Conference in New York, New York.
-
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
9/14/2023
Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, has launched a global roadshow called Cytek Reveal.
-
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
9/6/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Morgan Stanley 21st Annual Global Healthcare Conference in New York, New York.
-
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
8/28/2023
Cytek Biosciences, Inc., a leading cell analysis solutions company, announced the appointment of Philippe Busque, Ph.D. as Senior Vice President of Global Sales & Services.
-
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
8/10/2023
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 2023 UBS MedTech, Tools and Genomics Summit in Dana Point, CA.